Britannia completes previously announced non-brokered private placement for aggregate gross proceeds of CAD$931,000 Toronto, Ontario and London, United Kingdom–(Newsfile Corp. – July 22, 2024) – Britannia Life Sciences Inc...
Read more
Britannia will undertake a non-brokered private placement of units consisting of subordinated dentures and common shares for aggregate gross proceeds of up to CAD$1,000,000 Toronto, Ontario and London, United Kingdom–(Newsfile Corp. –...
Read more
New cosmetic product safety regulations in the U.S. will usher in more stringent compliance and reporting requirements ADSL to initially offer U.S. clients access to its technology-enabled safety and registration platform, as well as Responsible...
Read more
Britannia Life Sciences Inc. is pleased to announce the appointment of Mark Bowes-Cavanagh as Chief Executive Officer of its Global Consumer Products Division. In this additional role, Mr. Bowes-Cavanagh will lead the integration and continued...
Read more
Britannia Life Sciences Inc. is pleased to provide its unaudited financial results for the three- and six- month periods ended September 30, 2023. These filings and additional information regarding Britannia are available for review on SEDAR...
Read more
Get in touch with our team of professionals and let’s start a conversation.